Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis.

Sectors
Healthcare
Life Sciences
First Invested
2021
Early
Company Status